To Increase Patient Access
End Brain Cancer Mobile App to download your number one tool for navigating this disease.

Post Category: Glioblastoma

May 13, 2024
3 Brain Cancer Patients Who Are Inspiring HOPE

Every May EBCI has presented the HOPE award to a brain cancer patient who inspires us with their courage and hope in the face of this devastating disease.

Read More
March 26, 2024
EBCI Looking to Partner with GBM Drug Development Companies to Enhance Our Fight for GBM Patient Access

The End Brain Cancer Initiative (EBCI) will attend the Glioblastoma Drug Development Summit in Boston to insert the patient voice into trial protocols and patient disease education and awareness campaigns.

Read More
January 9, 2024
ONLY FOUR SPOTS LEFT! Opportunity for Patients Living with rGBM

Patients and caregivers dealing with first recurrence glioblastoma are being sought for an important survey. Make your voice heard.

Read More
December 15, 2023
Shuttle Pharma Advances Patient-Centric Breakthrough for Glioblastoma Treatment

Shuttle Pharmaceuticals has submitted a new drug for FDA approval to improve the effectiveness of radiation therapy for GBM patients.

Read More
October 14, 2023
Living with Recurrent Glioblastoma

Patients and caregivers dealing with first recurrence glioblastoma are being sought for an important survey. Make your voice heard.

Read More
September 7, 2023
rGBM Patients Encouraged to Share Their Experience

Jenn Ortiz, a two-time brain tumor survivor, describes her participation in the Patient Reported Outcomes rGBM study.

Read More
September 6, 2023
Gleolan Tumor Imaging Agent

Gleolan Brain Dye, imaging agent, helps neurosurgeons to see “high grade gliomas” during surgery. Learn about Gleolan.

Read More
September 6, 2023
More Great News For The Fight Against GBM! DCVax

Northwest Biotherapeutics has applied for approval to market DCVax®, a personalized immune therapy, for the treatment of Glioblastoma.

Read More
July 8, 2023
rGBM Study: Share Your Experience and Shape Future Treatments for GBM

We are looking for Glioblastoma (GBM) patients and their caregivers to participate in an important study on recurrent GBM.

Read More
July 7, 2023
Recruiting Now for Patients with Recurrent GBM

We are looking to interview patients, and their caregivers, who are living with recurrent glioblastoma (GBM).

Read More
June 29, 2023
Glioblastoma Symptoms: How to Spot the Signs of This Deadly Brain Cancer Tumor

Glioblastoma overview with a description of the symptoms of this treatment-resistant brain cancer.

Read More
June 22, 2023
2023 Hope Award Runner Up

Jennifer Ortiz Is the 1st runner-up recipient of the 2023 EBCI National HOPE Award.

Read More


Enhancing patient outcomes by expanding FDA-approved treatment modalities and fueling research in the pharma/bio/life sciences, device & diagnostic industries and by closing the existing GAP from initial diagnosis to IMMEDIATE AND EXPANDED ACCESS to specialists, researchers, advanced & innovative treatments, clinical trials and critical care with the ultimate goal of improving patient outcomes through updating and improving WHO & NCCN Guidelines and clinical practices related to Standard of Care for brain cancer patients.

TAX ID:26-2185614
corporate partners
upcoming events
About us
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram